Increasing incidence of scabies in France, 1999-2010, and public health implications;La gale en France entre 1999 et 2010: Augmentation de l'incidence et implications en santé publique

Annales de Dermatologie et de Venereologie

Volumn 139, Issue 6-7, 2012, Pages 428-434

  Bitar, D ^a   Thiolet, J M ^a   Haeghebaert, S ^b   Castor, C ^c   Poujol, I ^a   Coignard, B ^a   Che, D ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b ARS Nord Pas de Calais   (France)

^c CS 91704   (France)

Author keywords

Epidemiology; Incidence; Increase; Scabies

Indexed keywords

BENZYL BENZOATE; IVERMECTIN;

ARTICLE; FRANCE; INCIDENCE; PUBLIC HEALTH; SCABIES;

ANTIPARASITIC AGENTS; BENZOATES; BIAS (EPIDEMIOLOGY); CROSS INFECTION; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FORECASTING; FRANCE; HEALTH SURVEYS; HUMANS; INCIDENCE; INSECTICIDES; IVERMECTIN; PUBLIC HEALTH; RECURRENCE; SCABIES;

EID: 84862854263     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2012.01.023     Document Type: Article

References (27)

1. Poujol I, Thiolet JM, Bernet C, Carbonne A, Dumartin C, Sénéchal H. Signalements externes des infections nosocomiales, France, 2007-2009. Bull Epidemiol Hebd 2010;38-39:393-7.
2. Conseil supérieur d'hygiène publique de France. Avis du Conseil supérieur d'hygiène publique de France, section des maladies transmissibles, relatif à la conduite à tenir devant un cas de gale. 27 juin 2003; URL : http://www.sante.gouv.fr/ IMG/pdf/Avis-du- conseil-superieur-d-hygiene-publique-de-france-section-des-maladies- transmissibles-relatif-a-la-conduite-a-tenir-devant-un-cas-de-gale-seance-du-27- juin-2003 .pdf.
3. Conseil supérieur d'hygiène publique de France. Guide des conduites à tenir en cas de maladie transmissible dans une collectivité d'enfants. Ministère de la Santé, 2003; URL : http://www.sante.gouv.fr/IMG/pdf/Guide-des-conduites-a-tenir-en-cas-de-maladie- transmissible-dans-une-collectivite-d-enfants.pdf.
4. Afssaps. Analyse des ventes de médicaments aux officines et aux hôpitaux en France, 1999-2009. Juillet 2011, 11 (édition, 132 pages). URL : http://www.afssaps.fr/var/afssaps site/ storage/original/ application/6949f3707b826ada566544613ee8 dafe.pdf.
5. Buffet M, Dupin N. Current treatments for scabies. Fundam Clin Pharmacol 2003;17:217-25. (Pubitemid 36513214)
6. Chosidow O. Clinical practices. Scabies. N Engl J Med 2006;354:1718-27.
7. Hu S, Bigby M. Treating scabies: results from an updated Cochrane review. Arch Dermatol 2008;144:1638-40.
8. Ly F, Caumes E, Ndaw CA, Ndiaye B, Mahe A. Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial. Bull World Health Organ 2009;87:424-30.
9. Ancelle T. Statistique, épidémiologie Maloine eds. 2002, 300 p.
10. Dupuy A, Dehen L, Bourrat E, Lacroix C, Benderdouche M, Dubertret L, et al. Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol 2007;56: 53-62. (Pubitemid 44969301)
11. Downs AM, Harvey I, Kennedy CT. The epidemiology of head lice and scabies in the UK. Epidemiol Infect 1999;122: 471-7. (Pubitemid 29376086)
12. Pannell RS, Fleming DM, Cross KW. The incidence of molluscum contagiosum, scabies and lichen planus. Epidemiol Infect 2005;133:985-91. (Pubitemid 41699934)
13. Lapeere H, Naeyaert JM, De WJ, De MJ, Brochez L. Incidence of scabies in Belgium. Epidemiol Infect 2008;136:395-8. (Pubitemid 351233854)
14. Owusu-Edusei KJJr, Chesson HW, Gift TL. The economic burden of pediculosis pubis and scabies infections treated on an outpatient basis in the United States: evidence from private insurance claims data, 2001-2005. Sex Transm Dis 2009;36:297-9.
15. Caumes E, Danis M. Nouvelles indications de l'ivermectine. Rev Med Interne 2001;22:379-84. (Pubitemid 32303709)
16. Fox LM. Ivermectin: uses and impact 20 years on. Curr Opin Infect Dis 2006;19:588-93. (Pubitemid 44665466)
17. Prichard RK. Anthelmintics and control. Vet Parasitol 1988;27:97-109. (Pubitemid 18057953)
18. Sutherland IH. Veterinary use of ivermectin. Acta Leiden 1990;59:211-6. (Pubitemid 20199526)
19. Chosidow O, Giraudeau B, Cottrell J, Izri A, Hofmann R, Mann SG, et al. Oral ivermectin versus malathion lotion for difficult-to- treat head lice. N Engl J Med 2010;362:896-905.
20. Ameen M, Arenas R, Villanueva-Reyes J, Ruiz-Esmenjaud J, Millar D, Dominguez-Duenas F, et al. Oral ivermectin for treatment of pediculosis capitis. Pediatr Infect Dis J 2010;29:991-3.
21. Christophersen J. The epidemiology of scabies in Denmark, 1900 to 1975. Arch Dermatol 1978;114:747-50. (Pubitemid 8331235)
22. Davis RF, Johnston GA, Sladden MJ. Recognition and management of common ectoparasitic diseases in travelers. Am J Clin Dermatol 2009;10:1-8.
23. Diaz JH. Mite-transmitted dermatoses and infectious diseases in returning travelers. J Travel Med 2010;17:21-31.
24. Walton SF, Currie BJ. Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev 2007;20:268-79. (Pubitemid 46709305)
25. Hong MY, Lee CC, Chuang MC, Chao SC, Tsai MC, Chi CH. Factors related to missed diagnosis of incidental scabies infestations in patients admitted through the emergency department to inpatient services. Acad Emerg Med 2010;17:958-64.
26. Mounsey KE, Holt DC, McCarthy J, Currie BJ, Walton SF. Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol 2008;3:57-66. (Pubitemid 351385951)
27. Wolf R, Davidovici B. Treatment of scabies and pediculosis: facts and controversies. Clin Dermatol 2010;28:511-8.